Community-reported Campath side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Campath Side Effect Episode
Have You dealt with a Campath side effect? Share your experience
Review Campath Safety Reports submitted to FDA
Total Campath reports: 186.Campath FDA safety alerts: No.
Reported deaths: 67 Reported hospitalizations: 117.
Take Campath Side Effects Survey, Discuss Campath with others
FDA Reported Campath Side Effects: renal failure acute, pancytopenia, diarrhoea, autoimmune disorder, death, pyrexia, bacteraemia, confusional state, febrile neutropenia, hypoxia, malignant neoplasm progression.
More About Campath.
If you have questions about Campath, you can ask a Health Expert or Ask Patient Community about Campath.
Showing 1-100 of 186 Next >
Campath Side Effects Report #5374401-1Physician from UNITED STATES reported CAMPATH problem on June 22, 2007. Female patient, 64 years of age, weighting 142.0 lb, was diagnosed with wolff-parkinson-white syndrome, infection prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: diarrhoea, injection site infection, malignant neoplasm progression, mycobacterium chelonei infection. CAMPATH dosage: unknown. During the same period patient was treated with PREVACID, TENORMIN, ACYCLOVIR, BACTRIM, PYRIDIUM. Patient died on 01/01/2007.
Campath Side Effects Report #5047367-1
CAMPATH problem was reported by a Physician from GERMANY on June 19, 2006. Male patient, 42 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune thyroiditis, human herpes virus 6 serology positive, pancytopenia, rash, urticaria. CAMPATH dosage: 3/10/30 MG/D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5049704-0
Physician from UNITED STATES reported CAMPATH problem on June 23, 2006. Male patient, 61 years of age, weighting 156.5 lb, was diagnosed with bone marrow conditioning regimen, colony stimulating factor prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bacteraemia, band neutrophil percentage increased, blood alkaline phosphatase increased, blood glucose increased, blood lactate dehydrogenase increased, central line infection, coombs test positive, dehydration, diffuse large b-cell lymphoma. CAMPATH dosage: 50 MG D-7 TO D-3; INTRAVENOUS. During the same period patient was treated with FLUDARABINE, LEUKINE, MESNA, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CIDOFOVIR, ELECTROLYTE SOLUTIONS, IV SOLUTIONS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5049766-0
CAMPATH problem was reported by a Physician from UNITED STATES on June 23, 2006. Male patient, 61 years of age, weighting 156.5 lb, was diagnosed with bone marrow conditioning regimen, colony stimulating factor prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood creatinine increased, blood glucose increased, central line infection, dehydration, diffuse large b-cell lymphoma, haematocrit decreased, haemolysis, lymphadenopathy. CAMPATH dosage: 50 MG D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, LEUKINE, CYCLOPHOSPHAMIDE, MESNA, CYCLOSPORINE, CIDOFOVIR, ELECTROLYTE SOLUTIONS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5050358-8
Physician from UNITED STATES reported CAMPATH problem on June 22, 2006. Male patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic lymphocytic leukaemia, colony stimulating factor prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, candida sepsis, chronic lymphocytic leukaemia transformation, coombs positive haemolytic anaemia, cytomegalovirus infection, eosinophilia, haemolysis, marrow hyperplasia, myelodysplastic syndrome. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, LEUKINE, RITUXIMAB, CYCLOPHOSPHAMIDE, NEUPOGEN, PROCRIT. Patient was hospitalized. Patient died.
Campath Side Effects Report #5058457-1
CAMPATH problem was reported by a Physician from FRANCE on July 13, 2006. Female patient, 68 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholangitis sclerosing. CAMPATH dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with BACTRIM, VALACYCLOVIR, LEDERFOLIN. Patient recovered.
Campath Side Effects Report #5058458-3
Health Professional from GERMANY reported CAMPATH problem on July 04, 2006. Male patient, 65 years of age, weighting 205.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, ear pain, middle ear disorder, tongue neoplasm. CAMPATH dosage: 30 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHAT, COTRIM DS, FAMVIR, NORMOC, PANTOZOL, TRAMADOL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5072977-5
CAMPATH problem was reported by a Pharmacist from UNITED KINGDOM on July 20, 2006. Male patient, 68 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: atrioventricular block third degree. CAMPATH dosage: unknown. Patient was hospitalized. Patient died on 04/10/2006.
Campath Side Effects Report #5073492-5
Pharmacist from IRELAND reported CAMPATH problem on July 18, 2006. Male patient, 69 years of age, was treated with CAMPATH. CAMPATH dosage: unknown. Patient died.
Campath Side Effects Report #5075875-6
CAMPATH problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 64 years of age, was diagnosed with prolymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, bacteria stool identified, body temperature increased, clostridial infection, dehydration, fatigue, febrile neutropenia, heart rate increased. CAMPATH dosage: 10MG SQ DAY #1 Q 3 WEEKS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5080018-9
Health Professional from GERMANY reported CAMPATH problem on July 24, 2006. Male patient, 65 years of age, weighting 205.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, diffuse large b-cell lymphoma, ear pain, middle ear disorder, tongue neoplasm. CAMPATH dosage: 30 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, COTRIM DS, FAMVIR, NORMOC, PANTOZOL, TRAMADOL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5080232-2
CAMPATH problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacteraemia, condition aggravated, confusional state, hyponatraemia, lethargy, renal failure, urinary retention, urinary tract infection. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, EPOETIN ALFA, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5081146-4
Health Professional from UNITED STATES reported CAMPATH problem on July 27, 2006. Female patient, 45 years of age, weighting 158.7 lb, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anastomotic haemorrhage, complications of transplanted liver, haemodialysis, hepatic encephalopathy, hepatic failure, hepatic necrosis, hypotension, hypoxia, left ventricle outflow tract obstruction. CAMPATH dosage: 30 MG, 1 DOSE ON DAY 0, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, METHYLPREDNISOLONE, ACETAMINOPHEN, BENADRYL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5081148-8
CAMPATH problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Male patient, 79 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose decreased, body temperature increased, coma, feeling abnormal, gait disturbance. CAMPATH dosage: unknown. During the same period patient was treated with XOPENEX, LABETALOL, LASIX, COUMADIN, GLYBURIDE, BACTRIM. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5085057-X
Physician from UNITED STATES reported CAMPATH problem on Aug 04, 2006. Female patient, 47 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: condition aggravated, multiple sclerosis. CAMPATH dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5085332-9
CAMPATH problem was reported by a Physician from UNITED KINGDOM on Aug 07, 2006. Male patient, 68 years of age, weighting 220.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, atrioventricular block third degree, bradycardia, chronic lymphocytic leukaemia, fall, malignant neoplasm progression, nosocomial infection. CAMPATH dosage: 30 MG, 3X/WEEK, SUBCUTANEOUS. During the same period patient was treated with ACYCLOVIR, AMILORIDE, BUMETANIDE, LANSOPRAZOLE, PREDNISOLONE, ITRACONAZOLE. Patient was hospitalized. Patient died on 04/10/2006.
Campath Side Effects Report #5086860-2
Physician from UNITED STATES reported CAMPATH problem on Aug 15, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia, confusional state, escherichia bacteraemia, hyperkalaemia, hyponatraemia, lethargy, pneumonia escherichia, renal failure. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, EPOETIN ALFA, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5090950-8
CAMPATH problem was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, benign prostatic hyperplasia, catheter related infection, escherichia bacteraemia, hyperkalaemia, hyponatraemia, hypoxia, lethargy. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, EPOETIN ALFA, NORMAL SALINE, IMIPENEM, AZTREONAM, RED BLOOD CELLS, VITAMINS, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5090958-2
Physician from UNITED STATES reported CAMPATH problem on Aug 16, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anaemia, bacteraemia, benign prostatic hyperplasia, body temperature increased, confusional state, hyperkalaemia, hyponatraemia, hypoxia. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, DIPHENHYDRAMINE, ACETAMINOPHEN, EPOETIN ALFA, RED BLOOD CELLS, RED BLOOD CELLS, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5090965-X
CAMPATH problem was reported by a Physician from UNITED STATES on Aug 15, 2006. Female patient, 59 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. CAMPATH dosage: 50 MG/D D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA, LEUKINE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5092392-8
Physician from UNITED STATES reported CAMPATH problem on Aug 14, 2006. Male patient, 82 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: amnesia, anorexia, asthma, blood pressure decreased, catheter site pain, chills, delusion, disorientation, dysgraphia. CAMPATH dosage: unknown. During the same period patient was treated with TYLENOL, BENADRYL, DECADRON, BACTRIM. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5092776-8
CAMPATH problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia, benign prostatic hyperplasia, catheter related infection, dyspnoea, escherichia bacteraemia, hyponatraemia, hypoxia, lethargy, lung infiltration. CAMPATH dosage: unknown. During the same period patient was treated with FLUDURAECTION, EPOETIN ALFA, NORMAL SALINE, IMIPENEM, AZTREONAM, RED BLOOD CELLS, VITAMINS, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5095219-3
Physician from UNITED STATES reported CAMPATH problem on Aug 16, 2006. Female patient, 36 years of age, weighting 169.8 lb, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood urea increased, liver transplant rejection, marrow hyperplasia, pancytopenia. CAMPATH dosage: 30 MG, 1 DOSE D+4, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, NEORAL, GANCICLOVIR, HUMULIN, MORPHINE, ULTRAM, NEUPOGEN, AVANDIA. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5096412-6
CAMPATH problem was reported by a Health Professional from GERMANY on Aug 16, 2006. Male patient, 65 years of age, weighting 205.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, diffuse large b-cell lymphoma, dysphagia, ear discomfort, ear pain, glossodynia, lymphadenopathy, middle ear disorder. CAMPATH dosage: 30 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, COTRIM DS, FAMVIR, NORMOC, PANTOZOL, TRAMADOL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5100736-3
Physician from UNITED STATES reported CAMPATH problem on Aug 22, 2006. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, dialysis, hodgkin's disease, lung infection, malignant neoplasm progression, platelet count decreased, pleural effusion, pulmonary haemorrhage. CAMPATH dosage: 50 MG, D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA. Patient was hospitalized. Patient died on 08/10/2006.
Campath Side Effects Report #5105185-X
CAMPATH problem was reported by a Physician from UNITED STATES on Sept 05, 2006. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, lung infection, malignant neoplasm progression, myopathy steroid, pleural effusion, pulmonary haemorrhage, renal failure, respiratory failure. CAMPATH dosage: 50 MG, D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA, BACTRIM, MS CONTIN, VICODIN, MS CONTIN, LEVOTHYROXINE. Patient was hospitalized. Patient died on 08/10/2006.
Campath Side Effects Report #5106474-5
Health Professional from UNITED STATES reported CAMPATH problem on Sept 05, 2006. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aortic valve calcification, aortic valve incompetence, aspergillosis, atelectasis, atrial fibrillation, catheter related infection, condition aggravated, enterococcal infection. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, EPOETIN ALFA, NORMAL SALINE, IMIPENEM, AZTREONAM, RED BLOOD CELLS, VITAMINS, ALLOPURINOL. Patient was hospitalized. Patient died on 09/04/2006.
Campath Side Effects Report #5113751-0
CAMPATH problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, weighting 190.5 lb, was diagnosed with immunosuppression and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dyspnoea, heart rate increased, po2 decreased, throat tightness. CAMPATH dosage: 30 MG IV (2ND DOSE). During the same period patient was treated with APAP, ACYCLOVIRA, BENADRYL, COLACE, PREVACID, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5118693-2
Physician from IRELAND reported CAMPATH problem on Sept 18, 2006. Male patient, 69 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute tonsillitis, arteriosclerosis coronary artery, confusional state, diffuse alveolar damage, febrile neutropenia, mediastinal disorder, multi-organ failure, pulmonary oedema, renal failure. CAMPATH dosage: unknown. During the same period patient was treated with METHYLPREDNISONE. Patient was hospitalized. Patient died on 07/02/2006.
Campath Side Effects Report #5119066-9
CAMPATH problem was reported by a Health Professional from UNITED STATES on Sept 15, 2006. Female patient, 41 years of age, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, bile duct stenosis, biloma, haematocrit decreased, headache, hepatic failure, hepatic necrosis, liver transplant rejection, splenomegaly. CAMPATH dosage: 30 MG, 1 DOSE, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, PROTONIX, SEPTRA, VALCYTE, NORVASC, ACTIGALL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5119479-5
Physician from UNITED STATES reported CAMPATH problem on Sept 20, 2006. Male patient, 86 years of age, weighting 119.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: abscess, cachexia, chills, chronic lymphocytic leukaemia, computerised tomogram abnormal, confusional state, coronary artery disease, diarrhoea, febrile neutropenia. CAMPATH dosage: 30 MG, D1-5 EVERY 28 DAYS, SUBCUTANEOUS. During the same period patient was treated with FLUDARA, NEUPOGEN, ARANESP, CEFEPIME, VANCOMYCIN, MORPHINE. Patient was hospitalized. Patient died on 04/15/2006.
Campath Side Effects Report #5121398-5
CAMPATH problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2006. Male patient, 81 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aspiration, back pain, demyelinating polyneuropathy, dyspnoea, muscle spasms, pyrexia. CAMPATH dosage: 30 MG, 2X/WEEK, SUBCUTANEOUS; SEE IMAGE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5129523-7
Physician from UNITED STATES reported CAMPATH problem on Oct 05, 2006. Female patient, 39 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, cardiac failure congestive, cerebral infarction, coagulopathy, condition aggravated, decubitus ulcer, diarrhoea, enterococcal bacteraemia. CAMPATH dosage: 90 MG TOTAL, OVER 4 DAYS, INTRAVENOUS. During the same period patient was treated with FLUDARA, LEUKINE, MELPHALAN, SULFAMETHOXAZOLE, VORICONAZOLE. Patient was hospitalized. Patient died on 02/27/2006.
Campath Side Effects Report #5153529-5
CAMPATH problem was reported by a Consumer or non-health professional from AUSTRIA on Oct 26, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cardiac failure. CAMPATH dosage: 3 MG, 1 DOSE ; 10 MG, 1 DOSE ; 30 MG , 1 DOSE ; 30 MG, 3X/WEEK. During the same period patient was treated with VALACYCLOVIR, SULFAMETHOXAZOLE. Patient died.
Campath Side Effects Report #5153674-4
Consumer or non-health professional from AUSTRIA reported CAMPATH problem on Oct 26, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. CAMPATH dosage: unknown. During the same period patient was treated with VALACYCLOVIR, SULFAMETHOXAZOLE. Patient died.
Campath Side Effects Report #5165728-7
CAMPATH problem was reported by a Physician from FRANCE on Nov 20, 2006. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: amyotrophy, gait disturbance. CAMPATH dosage: unknown. Patient recovered.
Campath Side Effects Report #5169286-2
Physician from UNITED KINGDOM reported CAMPATH problem on Nov 20, 2006. Male patient was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, thrombocytopenia. CAMPATH dosage: unknown. Patient recovered.
Campath Side Effects Report #5169323-5
CAMPATH problem was reported by a Health Professional from FRANCE on Nov 28, 2006. Male patient, 83 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholestasis, platelet count decreased. CAMPATH dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with RYTHMOL, ALLOPURINOL, AMLODIPINE BESYLATE, FONZYLANE, PRAVASTATIN, PREVISCAN. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5169379-X
Consumer or non-health professional from UNITED STATES reported CAMPATH problem on Nov 27, 2006. Male patient, 81 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aspiration, back pain, body temperature increased, demyelinating polyneuropathy, dyspnoea. CAMPATH dosage: 30 MG, 2X/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5169547-7
CAMPATH problem was reported by a Health Professional from UNITED STATES on Nov 29, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: dialysis, neutropenia, night sweats, pyrexia, renal failure acute, tremor. CAMPATH dosage: 30 MG /DAY, D1-5 EVERY 28 DAYS, SUBCUTANEOUS. During the same period patient was treated with FLUDARA, NEULASTA, LEVAQUIN, TYENOL, BACTRIM, FAMVIR, FLAGYL. Patient was hospitalized. Patient died on 11/28/2006.
Campath Side Effects Report #5169548-9
Physician from UNITED STATES reported CAMPATH problem on Nov 28, 2006. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: adenovirus infection, blood culture positive, cerebral atrophy, chronic lymphocytic leukaemia, convulsion, culture urine positive, disease progression, encephalopathy, febrile neutropenia. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA, ADRIAMYCIN PFS, RITUXAN, VINCRISTINE, NEULASTA, ADRIAMYCIN PFS. Patient was hospitalized. Patient died on 11/27/2006.
Campath Side Effects Report #5170082-0
CAMPATH problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Male patient, 83 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: dizziness postural, neuroendocrine carcinoma of the skin. CAMPATH dosage: unknown. Patient recovered.
Campath Side Effects Report #5170085-6
Health Professional from UNITED STATES reported CAMPATH problem on Nov 16, 2006. Male patient, 66 years of age, was diagnosed with liver transplant, prophylaxis against transplant rejection and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, acute respiratory failure, anaemia, asthenia, blood chloride decreased, blood glucose increased, blood potassium increased, blood pressure diastolic decreased, clostridium difficile colitis. CAMPATH dosage: unknown. During the same period patient was treated with TACROLIMUS, ATROVENT, PRILOSEC, COMBIVENT, AMIODARONE, DAPSONE. Patient died on 02/04/2006.
Campath Side Effects Report #5170095-9
CAMPATH problem was reported by a Health Professional from UNITED STATES on Nov 20, 2006. Female patient, 32 years of age, was diagnosed with multiple sclerosis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, hypothyroidism, pregnancy, treatment noncompliance. CAMPATH dosage: unknown. During the same period patient was treated with MIRCETTE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5170098-4
Consumer or non-health professional from UNITED STATES reported CAMPATH problem on Nov 29, 2006. Male patient, 83 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: dizziness postural, neoplasm recurrence, neuroendocrine carcinoma of the skin. CAMPATH dosage: unknown. Patient recovered.
Campath Side Effects Report #5178119-X
CAMPATH problem was reported by a Physician from UNITED STATES on Nov 27, 2006. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, dialysis, diarrhoea, electrolyte imbalance, failure to thrive, febrile neutropenia, haemodialysis, hepatic failure. CAMPATH dosage: unknown. During the same period patient was treated with PREDNISONE, FAMCICLOVIR, SULFAMETHOXAZOLE, FOLIC ACID, VITAMIN B6. Patient was hospitalized. Patient died on 04/20/2006.
Campath Side Effects Report #5178222-4
Health Professional from FRANCE reported CAMPATH problem on Nov 30, 2006. Male patient, 83 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholestasis, platelet count decreased. CAMPATH dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with RYTHMOL, ALLOPURINOL, AMLODIPINE BESYLATE, FONZYLANE, PRAVASTATIN, PREVISCAN. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5179940-4
CAMPATH problem was reported by a Health Professional from SWEDEN on Nov 30, 2006. Female patient, 65 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, arthropod bite, autoimmune neutropenia, biopsy bone marrow abnormal, blast cells present, lymphadenopathy, pyrexia, splenectomy, urticaria. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5184160-3
Physician from UNITED STATES reported CAMPATH problem on Dec 04, 2006. Male patient, 81 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: aspiration, autoimmune disorder, biopsy bone marrow abnormal, chronic inflammatory demyelinating polyradiculoneuropathy, dysgeusia, herpes simplex. CAMPATH dosage: unknown. Patient was hospitalized. Patient died on 10/24/2006.
Campath Side Effects Report #5191763-9
CAMPATH problem was reported by a Physician from FRANCE on Dec 05, 2006. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood bilirubin increased, cholangitis sclerosing, cholestasis, gamma-glutamyltransferase increased, varices oesophageal, vena cava thrombosis. CAMPATH dosage: 10 MG, CYCLES, INTRAVENOUS. During the same period patient was treated with DEPAKENE. Patient recovered.
Campath Side Effects Report #5192040-2
Health Professional from BULGARIA reported CAMPATH problem on Dec 06, 2006. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholangiolitis, hepatitis. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5192057-8
CAMPATH problem was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 83 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholestasis, lymphocytic infiltration. CAMPATH dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with RYTHMOL, ALLOPURINOL, AMLODIPINE BESYLATE, FONZYLANE, PRAVASTATIN, PREVISCAN. Patient was hospitalized. Patient died on 11/28/2006.
Campath Side Effects Report #5192547-8
Physician from FRANCE reported CAMPATH problem on Dec 06, 2006. Female patient, 68 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholangitis sclerosing. CAMPATH dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with BACTRIM, VALACYCLOVIR, LEDERFOLIN, CIBACEN. Patient recovered.
Campath Side Effects Report #5194310-0
CAMPATH problem was reported by a Physician from UNITED STATES on Dec 06, 2006. Female patient, 62 years of age, was diagnosed with prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, hepatitis cholestatic, staphylococcal infection. CAMPATH dosage: 30 MG, 1X/DAY. During the same period patient was treated with FLUDARABINE PHOSPHAT, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5194341-0
Health Professional from UNITED STATES reported CAMPATH problem on Nov 20, 2006. Female patient, 32 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. CAMPATH dosage: 24 MG, 1X/DAY. During the same period patient was treated with MIRCETTE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5291205-9
CAMPATH problem was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 52 years of age, was diagnosed with infection prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic. CAMPATH dosage: 30 MG/D, 1X/DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, ACYCLOVIR, ARGININE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5307429-8
Physician from UNITED STATES reported CAMPATH problem on Apr 10, 2007. Female patient, 62 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: neuropathy. CAMPATH dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5376530-5
CAMPATH problem was reported by a Pharmacist from UNITED KINGDOM on June 26, 2007. Male patient was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. CAMPATH dosage: 30 MG X3D PRIOR TO ICE TX. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died on 01/01/2007.
Campath Side Effects Report #5378087-1
Health Professional from UNITED STATES reported CAMPATH problem on July 02, 2007. Male patient, weighting 233.7 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CAMPATH dosage: unknown. During the same period patient was treated with ACTOPLUS, ALLOPURINOL, ATORVASTATIN, LASIX, ZOFRAN, CIPRO, NEULASTA, PREDNISONE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5381104-6
CAMPATH problem was reported by a Health Professional from UNITED STATES on June 26, 2007. Female patient, 31 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. CAMPATH dosage: 24 MG, 1X/DAY. During the same period patient was treated with MIRCETTE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5384017-9
Physician from UNITED STATES reported CAMPATH problem on May 21, 2006. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: progressive multifocal leukoencephalopathy. CAMPATH dosage: unknown. Patient died.
Campath Side Effects Report #5384018-0
CAMPATH problem was reported by a Pharmacist from UNITED STATES on Aug 09, 2006. Male patient, 81 years of age, was diagnosed with t-cell lymphoma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, chills. CAMPATH dosage: 30 MG IVP ; 30 MG, 3X/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5384029-5
Pharmacist from UNITED STATES reported CAMPATH problem on Oct 17, 2006. Female patient, 36 years of age, weighting 176.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood pressure decreased, febrile neutropenia, interstitial lung disease, parainfluenzae virus infection, pneumothorax, supraventricular tachycardia. CAMPATH dosage: unknown. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient died on 09/26/2006.
Campath Side Effects Report #5384040-4
CAMPATH problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bronchospasm. CAMPATH dosage: 3 MG, 1 DOSE, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5384046-5
Health Professional from UNITED STATES reported CAMPATH problem on May 03, 2007. Male patient, 44 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. CAMPATH dosage: unknown. Patient died on 02/26/2007.
Campath Side Effects Report #5384597-3
CAMPATH problem was reported by a Physician from UNITED KINGDOM on July 05, 2007. Male patient, 53 years of age, was diagnosed with mycosis fungoides, antibiotic prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, renal impairment, sarcoidosis. CAMPATH dosage: 30 MG, 3X/WEEK. During the same period patient was treated with ANTIINFECTIVES. Patient recovered.
Campath Side Effects Report #5386163-2
Health Professional from UNITED STATES reported CAMPATH problem on July 11, 2007. Male patient, weighting 233.7 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, febrile neutropenia, oxygen saturation decreased. CAMPATH dosage: unknown. During the same period patient was treated with ACTOPLUS, ALLOPURINOL, ATORVASTATIN, LASIX, ZOFRAN, CIPRO. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5389666-X
CAMPATH problem was reported by a Physician from GERMANY on July 13, 2007. Male patient, 60 years of age, weighting 187.4 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: infection. CAMPATH dosage: 3/10/30 MG. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5406394-2
Consumer or non-health professional from FRANCE reported CAMPATH problem on July 26, 2007. Male patient, 54 years of age, was diagnosed with mycosis fungoides and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chills, cholestasis, cough, cytolytic hepatitis, hypotension, lymphopenia, pyrexia. CAMPATH dosage: 3 MG, 1 DOSE. During the same period patient was treated with ATARAX. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5412685-1
CAMPATH problem was reported by a Consumer or non-health professional from RUSSIAN FEDERATION on Aug 02, 2007. Male patient, 58 years of age, was diagnosed with mantle cell lymphoma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, asthenia. CAMPATH dosage: 30 MG, 3X/WEEK. Patient recovered.
Campath Side Effects Report #5412687-5
Health Professional from UNITED STATES reported CAMPATH problem on Aug 07, 2007. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: bacteraemia, hyponatraemia, renal failure, urinary tract infection. CAMPATH dosage: 30 MG, D1-5 EVERY 28 DAYS. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5412690-5
CAMPATH problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Male patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: septic shock. CAMPATH dosage: 30 MG, 1X/DAY. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient died on 09/04/2006.
Campath Side Effects Report #5412717-0
Physician from UNITED STATES reported CAMPATH problem on Aug 02, 2007. Female patient, 20 years of age, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, transplant failure. CAMPATH dosage: unknown. Patient died.
Campath Side Effects Report #5415924-6
CAMPATH problem was reported by a Consumer or non-health professional from RUSSIAN FEDERATION on Aug 08, 2007. Male patient, 58 years of age, was diagnosed with mantle cell lymphoma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, asthenia. CAMPATH dosage: 30 MG, 3X/WEEK. During the same period patient was treated with COTRIM, VALACYCLOVIR, CIPROFLOXACIN, FLUCONAZOLE, LAMIVUDINE. Patient died on 04/24/2007.
Campath Side Effects Report #5417248-X
Health Professional from UNITED STATES reported CAMPATH problem on Aug 07, 2007. Male patient, 76 years of age, weighting 150.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. CAMPATH dosage: 30 MG/DAY D1-5 Q28 DAYS. During the same period patient was treated with FLUDARA, ALBUTEROL. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5422807-4
CAMPATH problem was reported by a Physician from GERMANY on Aug 20, 2007. Male patient, 60 years of age, weighting 187.4 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: infection. CAMPATH dosage: 3/10/30 MG. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5442624-9
Physician from UNITED STATES reported CAMPATH problem on Aug 27, 2007. Female patient was diagnosed with waldenstrom's macroglobulinaemia, infection prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia, von willebrand's disease. CAMPATH dosage: 3/10/30MG. During the same period patient was treated with ACYCLOVIR, BACTRIM. Patient died.
Campath Side Effects Report #5449248-8
CAMPATH problem was reported by a Consumer or non-health professional from VENEZUELA on Aug 30, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: pulmonary hypertension. CAMPATH dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE W, DAUNORUBICIN. Patient died.
Campath Side Effects Report #5449252-X
Physician from UNITED STATES reported CAMPATH problem on Aug 30, 2007. Female patient, 63 years of age, weighting 242.0 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: liver transplant rejection. CAMPATH dosage: 30 MG, 1 DOSE. During the same period patient was treated with TACROLIMUS, SEPTRA DS, INDERAL, PROTONIX, LASIX, NORVASC. Patient recovered.
Campath Side Effects Report #5452974-8
CAMPATH problem was reported by a Consumer or non-health professional from GERMANY on Sept 07, 2007. Male patient, 60 years of age, weighting 187.4 lb, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cholangitis suppurative. CAMPATH dosage: 3/10/30 MG. Patient was hospitalized. Patient died on 07/25/2003.
Campath Side Effects Report #5454468-2
Physician from UNITED STATES reported CAMPATH problem on Sept 04, 2007. Female patient, 21 years of age, was diagnosed with liver transplant and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, autoimmune hepatitis, bile duct stenosis, cardiac tamponade, pancreatitis, pericarditis, transplant failure. CAMPATH dosage: 30 MG, 1 DOSE. During the same period patient was treated with TACROLIMUS. Patient died.
Campath Side Effects Report #5463538-4
CAMPATH problem was reported by a Health Professional from UNITED KINGDOM on Sept 14, 2007. Male patient was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: infection. CAMPATH dosage: unknown. Patient died on 01/01/2007.
Campath Side Effects Report #5465941-5
Consumer or non-health professional from GERMANY reported CAMPATH problem on Sept 14, 2007. Female patient, 20 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, chronic graft versus host disease, hyperthyroidism. CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient recovered.
Campath Side Effects Report #5465942-7
CAMPATH problem was reported by a Consumer or non-health professional from GERMANY on Sept 14, 2007. Male patient, 40 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism. CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5469775-7
Pharmacist from UNITED STATES reported CAMPATH problem on Sept 26, 2007. Male patient, weighting 155.8 lb, was diagnosed with t-cell prolymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, chills, feeling cold, throat irritation. CAMPATH dosage: unknown. Patient recovered.
Campath Side Effects Report #5470664-2
CAMPATH problem was reported by a Consumer or non-health professional from GERMANY on Sept 14, 2007. Female patient, 17 years of age, was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, hyperthyroidism, hypothyroidism, inflammation, thyroiditis. CAMPATH dosage: 50 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Showing 1-100 of 186 Next >
Ask Our Patient Community about Campath |
||
|
|
||
|
|
||